Grantees must disclose financial interest in companies relevant to research

Share this article:
Researchers receiving grants from the National Institutes of Health would face tougher disclosure rules under an amendment to the economic stimulus bill introduced by Sens. Chuck Grassley (R-IA) and Herb Kohl (D-WI). The legislation would mandate that all grantees receiving funds in excess of $250,000 disclose the amount of the primary investigator's significant financial interest in companies relevant to the research. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.

Email Newsletters